JP2008515999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008515999A5 JP2008515999A5 JP2007536964A JP2007536964A JP2008515999A5 JP 2008515999 A5 JP2008515999 A5 JP 2008515999A5 JP 2007536964 A JP2007536964 A JP 2007536964A JP 2007536964 A JP2007536964 A JP 2007536964A JP 2008515999 A5 JP2008515999 A5 JP 2008515999A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- disease
- amd
- crig
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 58
- 229920001184 polypeptide Polymers 0.000 claims 29
- 102100017077 VSIG4 Human genes 0.000 claims 21
- 101700055320 VSIG4 Proteins 0.000 claims 21
- 206010064930 Age-related macular degeneration Diseases 0.000 claims 20
- 208000002780 Macular Degeneration Diseases 0.000 claims 20
- 208000005590 Choroidal Neovascularization Diseases 0.000 claims 10
- 206010060823 Choroidal neovascularisation Diseases 0.000 claims 10
- 230000000295 complement Effects 0.000 claims 9
- 201000010099 disease Diseases 0.000 claims 7
- 239000000556 agonist Substances 0.000 claims 6
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 claims 4
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 claims 4
- 102000018358 Immunoglobulins Human genes 0.000 claims 4
- 108060003951 Immunoglobulins Proteins 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 4
- 230000002265 prevention Effects 0.000 claims 4
- 208000006454 Hepatitis Diseases 0.000 claims 3
- 206010039073 Rheumatoid arthritis Diseases 0.000 claims 3
- 206010043778 Thyroiditis Diseases 0.000 claims 3
- 230000001684 chronic Effects 0.000 claims 3
- 239000004074 complement inhibitor Substances 0.000 claims 3
- 230000004927 fusion Effects 0.000 claims 3
- 102000037240 fusion proteins Human genes 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 231100000283 hepatitis Toxicity 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 201000006417 multiple sclerosis Diseases 0.000 claims 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 claims 2
- 208000005783 Autoimmune Thyroiditis Diseases 0.000 claims 2
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 2
- 206010018364 Glomerulonephritis Diseases 0.000 claims 2
- 102000009786 Immunoglobulin Constant Regions Human genes 0.000 claims 2
- 108010009817 Immunoglobulin Constant Regions Proteins 0.000 claims 2
- 206010021972 Inflammatory bowel disease Diseases 0.000 claims 2
- 206010061255 Ischaemia Diseases 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 claims 2
- 208000002098 Purpura, Thrombocytopenic, Idiopathic Diseases 0.000 claims 2
- 208000004644 Retinal Vein Occlusion Diseases 0.000 claims 2
- 208000006641 Skin Disease Diseases 0.000 claims 2
- 206010046851 Uveitis Diseases 0.000 claims 2
- 201000000028 adult respiratory distress syndrome Diseases 0.000 claims 2
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 2
- 230000002612 cardiopulmonary Effects 0.000 claims 2
- 201000005667 central retinal vein occlusion Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 201000001981 dermatomyositis Diseases 0.000 claims 2
- 230000037361 pathway Effects 0.000 claims 2
- 230000000069 prophylaxis Effects 0.000 claims 2
- 238000001356 surgical procedure Methods 0.000 claims 2
- 206010001897 Alzheimer's disease Diseases 0.000 claims 1
- 208000009094 Anemia, Hemolytic, Autoimmune Diseases 0.000 claims 1
- 208000003343 Antiphospholipid Syndrome Diseases 0.000 claims 1
- 206010003210 Arteriosclerosis Diseases 0.000 claims 1
- 208000006673 Asthma Diseases 0.000 claims 1
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 206010003827 Autoimmune hepatitis Diseases 0.000 claims 1
- 206010050245 Autoimmune thrombocytopenia Diseases 0.000 claims 1
- 206010004161 Basedow's disease Diseases 0.000 claims 1
- 206010004661 Biliary cirrhosis primary Diseases 0.000 claims 1
- 206010007554 Cardiac failure Diseases 0.000 claims 1
- 206010007625 Cardiogenic shock Diseases 0.000 claims 1
- 210000003169 Central Nervous System Anatomy 0.000 claims 1
- 206010008609 Cholangitis sclerosing Diseases 0.000 claims 1
- 206010072757 Chronic spontaneous urticaria Diseases 0.000 claims 1
- 108009000280 Complement Activation Proteins 0.000 claims 1
- 108010078015 Complement C3b Proteins 0.000 claims 1
- 208000010247 Contact Dermatitis Diseases 0.000 claims 1
- 206010055665 Corneal neovascularisation Diseases 0.000 claims 1
- 210000004351 Coronary Vessels Anatomy 0.000 claims 1
- 208000001309 Degenerative Myopia Diseases 0.000 claims 1
- 208000004275 Demyelinating Disease Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 206010012688 Diabetic retinal oedema Diseases 0.000 claims 1
- 206010014801 Endophthalmitis Diseases 0.000 claims 1
- 206010048554 Endothelial dysfunction Diseases 0.000 claims 1
- 206010015218 Erythema multiforme Diseases 0.000 claims 1
- 208000009745 Eye Disease Diseases 0.000 claims 1
- 206010018370 Glomerulonephritis membranoproliferative Diseases 0.000 claims 1
- 108010068370 Glutens Proteins 0.000 claims 1
- 206010018651 Graft versus host disease Diseases 0.000 claims 1
- 208000009329 Graft vs Host Disease Diseases 0.000 claims 1
- 208000003807 Graves Disease Diseases 0.000 claims 1
- 201000004779 Graves' disease Diseases 0.000 claims 1
- 208000001204 Hashimoto Disease Diseases 0.000 claims 1
- 206010019280 Heart failure Diseases 0.000 claims 1
- 102000001554 Hemoglobins Human genes 0.000 claims 1
- 108010054147 Hemoglobins Proteins 0.000 claims 1
- 208000005252 Hepatitis A Diseases 0.000 claims 1
- 208000002672 Hepatitis B Diseases 0.000 claims 1
- 208000005331 Hepatitis D Diseases 0.000 claims 1
- 206010019780 Hepatitis infectious Diseases 0.000 claims 1
- 206010019860 Hereditary angioedema Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000010159 IGA Glomerulonephritis Diseases 0.000 claims 1
- 206010021263 IgA nephropathy Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 208000001083 Kidney Disease Diseases 0.000 claims 1
- 210000004072 Lung Anatomy 0.000 claims 1
- 208000009856 Lung Disease Diseases 0.000 claims 1
- 208000005777 Lupus Nephritis Diseases 0.000 claims 1
- 208000004451 Membranoproliferative Glomerulonephritis Diseases 0.000 claims 1
- 229920001850 Nucleic acid sequence Polymers 0.000 claims 1
- 102100012341 PIGA Human genes 0.000 claims 1
- 101700037337 PIGA Proteins 0.000 claims 1
- 206010033661 Pancytopenia Diseases 0.000 claims 1
- 241000721454 Pemphigus Species 0.000 claims 1
- 210000001428 Peripheral Nervous System Anatomy 0.000 claims 1
- 208000005987 Polymyositis Diseases 0.000 claims 1
- 206010036105 Polyneuropathy Diseases 0.000 claims 1
- 208000004358 Polyneuropathy Diseases 0.000 claims 1
- 206010038436 Renal failure acute Diseases 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 208000007135 Retinal Neovascularization Diseases 0.000 claims 1
- 206010038932 Retinopathy Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 206010039710 Scleroderma Diseases 0.000 claims 1
- 208000010157 Sclerosing Cholangitis Diseases 0.000 claims 1
- 206010040767 Sjogren's syndrome Diseases 0.000 claims 1
- 208000006045 Spondylarthropathy Diseases 0.000 claims 1
- 206010052775 Spondyloarthropathy Diseases 0.000 claims 1
- 208000004732 Systemic Vasculitis Diseases 0.000 claims 1
- 206010042953 Systemic sclerosis Diseases 0.000 claims 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 206010048302 Tubulointerstitial nephritis Diseases 0.000 claims 1
- 206010046736 Urticarias Diseases 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 206010047931 Whipple's disease Diseases 0.000 claims 1
- 102000004965 antibodies Human genes 0.000 claims 1
- 108090001123 antibodies Proteins 0.000 claims 1
- 201000001320 atherosclerosis Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 201000000448 autoimmune hemolytic anemia Diseases 0.000 claims 1
- 201000009596 autoimmune hypersensitivity disease Diseases 0.000 claims 1
- 230000024203 complement activation Effects 0.000 claims 1
- 201000000159 corneal neovascularization Diseases 0.000 claims 1
- 201000003278 cryoglobulinemia Diseases 0.000 claims 1
- 201000003883 cystic fibrosis Diseases 0.000 claims 1
- 230000004340 degenerative myopia Effects 0.000 claims 1
- 231100000080 dermatitis contact Toxicity 0.000 claims 1
- 201000011190 diabetic macular edema Diseases 0.000 claims 1
- 201000009273 endometriosis Diseases 0.000 claims 1
- 201000009580 eosinophilic pneumonia Diseases 0.000 claims 1
- 230000003176 fibrotic Effects 0.000 claims 1
- 235000021312 gluten Nutrition 0.000 claims 1
- 201000007192 granulomatous hepatitis Diseases 0.000 claims 1
- 238000001631 haemodialysis Methods 0.000 claims 1
- 230000000322 hemodialysis Effects 0.000 claims 1
- 201000001066 hemolytic-uremic syndrome Diseases 0.000 claims 1
- 201000010229 hepatobiliary disease Diseases 0.000 claims 1
- 201000002563 histoplasmosis Diseases 0.000 claims 1
- 230000009610 hypersensitivity Effects 0.000 claims 1
- 201000009794 idiopathic pulmonary fibrosis Diseases 0.000 claims 1
- 230000002757 inflammatory Effects 0.000 claims 1
- 200000000018 inflammatory disease Diseases 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000000366 juvenile Effects 0.000 claims 1
- 201000002481 myositis Diseases 0.000 claims 1
- 230000000422 nocturnal Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000000414 obstructive Effects 0.000 claims 1
- 230000001314 paroxysmal Effects 0.000 claims 1
- 201000003045 paroxysmal nocturnal hemoglobinuria Diseases 0.000 claims 1
- 201000002728 primary biliary cirrhosis Diseases 0.000 claims 1
- 201000004681 psoriasis Diseases 0.000 claims 1
- 230000002685 pulmonary Effects 0.000 claims 1
- 201000000306 sarcoidosis Diseases 0.000 claims 1
- 201000005671 spondyloarthropathy Diseases 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 201000009594 systemic scleroderma Diseases 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 201000003067 thrombocytopenia due to platelet alloimmunization Diseases 0.000 claims 1
- 200000000020 tissue injury Diseases 0.000 claims 1
- 230000002485 urinary Effects 0.000 claims 1
- 208000006542 von Hippel-Lindau Disease Diseases 0.000 claims 1
Claims (55)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/964,263 | 2004-10-12 | ||
US10/964,263 US7419663B2 (en) | 1998-03-20 | 2004-10-12 | Treatment of complement-associated disorders |
US11/159,919 US8088386B2 (en) | 1998-03-20 | 2005-06-22 | Treatment of complement-associated disorders |
US11/159,919 | 2005-06-22 | ||
PCT/US2005/037114 WO2006042329A2 (en) | 2004-10-12 | 2005-10-12 | Crig polypeptide for prevention and treatment of complement-associated disorders |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011197573A Division JP2011246495A (en) | 2004-10-12 | 2011-09-09 | Crig polypeptide for prevention and treatment of complement-associated disorder |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2008515999A JP2008515999A (en) | 2008-05-15 |
JP2008515999A5 true JP2008515999A5 (en) | 2008-11-13 |
JP4897690B2 JP4897690B2 (en) | 2012-03-14 |
Family
ID=45418822
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007536964A Expired - Fee Related JP4897690B2 (en) | 2004-10-12 | 2005-10-12 | CRIg polypeptide for prevention and treatment of complement related disorders |
JP2011197573A Withdrawn JP2011246495A (en) | 2004-10-12 | 2011-09-09 | Crig polypeptide for prevention and treatment of complement-associated disorder |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011197573A Withdrawn JP2011246495A (en) | 2004-10-12 | 2011-09-09 | Crig polypeptide for prevention and treatment of complement-associated disorder |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP4897690B2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2844250B1 (en) * | 2012-05-01 | 2017-11-08 | Translatum Medicus Inc. | Methods for treating and diagnosing blinding eye diseases |
CN104428000A (en) * | 2012-05-02 | 2015-03-18 | 纽约大学 | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
WO2022010273A1 (en) * | 2020-07-07 | 2022-01-13 | 주식회사 카나프테라퓨틱스 | Fusion proteins comprising complement pathway inhibitor and use thereof |
CN112364512B (en) * | 2020-11-13 | 2024-03-08 | 华东理工大学 | Ethylene cracking furnace load optimization method based on Baowier search algorithm |
KR20230105972A (en) | 2022-01-05 | 2023-07-12 | 주식회사 카나프테라퓨틱스 | ANTI-C3b ANTIBODY OR ANTI-C5 ANTIBODY CONJUGATED WITH ANGIOGENESIS INHIBITOR AND USE THEREOF |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9301289D0 (en) * | 1993-01-22 | 1993-03-17 | Smithkline Beecham Plc | Novel composition |
DK1481989T3 (en) * | 1997-11-21 | 2008-08-25 | Genentech Inc | A-33-related antigens and their pharmacological uses |
US7192589B2 (en) * | 1998-09-16 | 2007-03-20 | Genentech, Inc. | Treatment of inflammatory disorders with STIgMA immunoadhesins |
EP1220905A2 (en) * | 1999-03-08 | 2002-07-10 | Genentech Inc. | Composition and methods for the treatment of immune related diseases |
JP2003514541A (en) * | 1999-11-19 | 2003-04-22 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 18 human secreted proteins |
AU2003258714A1 (en) * | 2002-09-06 | 2004-03-29 | Cytos Biotechnology Ag | Immune modulatory compounds and methods |
WO2004028635A1 (en) * | 2002-09-27 | 2004-04-08 | Novartis Ag | Ocular gene therapy |
-
2005
- 2005-10-12 JP JP2007536964A patent/JP4897690B2/en not_active Expired - Fee Related
-
2011
- 2011-09-09 JP JP2011197573A patent/JP2011246495A/en not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20161580T1 (en) | AFFINITY MATURED CRIg VARIANTS | |
JP2008515999A5 (en) | ||
JP2011504872A5 (en) | ||
JP2016222702A5 (en) | ||
RU2009149385A (en) | ANTIBODIES AGAINST С3b AND METHODS OF PREVENTION AND TREATMENT OF COMPLIANCE-BASED VIOLATIONS | |
RU2019102393A (en) | HUMANIZED ANTIBODIES TO FACTOR D AND THEIR APPLICATION | |
US10858420B2 (en) | Methods of treating hemolytic disorders comprising administering an anti-C3b antibody | |
JP2010511056A5 (en) | ||
JP2014516945A5 (en) | ||
US20190161755A1 (en) | Compositions and methods for inhibiting factor d | |
JP2007514419A5 (en) | ||
JP2011519950A5 (en) | ||
JP2015526064A5 (en) | ||
US20060188505A1 (en) | Treatment of autism | |
RU2011110169A (en) | ANTIBODIES AGAINST CCR2 | |
JP2017536357A5 (en) | ||
JP2019503167A5 (en) | ||
CN106661128A (en) | Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof | |
JP2018511609A5 (en) | ||
JP2019537437A5 (en) | ||
JP2013527144A5 (en) | ||
HRP20191945T1 (en) | Improved il-6 antibodies | |
JP2019510078A5 (en) | ||
JP2019503706A5 (en) | ||
JP2020019813A5 (en) |